Viewing Study NCT00372567


Ignite Creation Date: 2025-12-25 @ 12:35 AM
Ignite Modification Date: 2026-06-14 @ 12:49 PM
Study NCT ID: NCT00372567
Status: TERMINATED
Last Update Posted: 2011-03-17
First Post: 2006-09-05
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Safety And Effectiveness Of Daily Dosing With Sunitinib Or Imatinib In Patients With Gastrointestinal Stromal Tumors
Sponsor: Pfizer
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Gastrointestinal Stromal Tumor View
Keywords: